Meet our Sponsors
Becoming a sponsor is easy: there are sponsorship opportunities at various price points, and all the opportunities come with valuable benefits. Create a tailored package that suits your goals and budget by selecting from the wide range of opportunities.
Please contact us if you wish to support the conference in a way not detailed in our prospectus.
Platinum Sponsor
National Cancer Institute (NCI) is part of the NIH, one of 11 agencies that are part of the U.S. Department of Health and Human Services. NCI coordinates the U.S. National Cancer Program, which conducts and supports research, training, health information dissemination and other activities related to the cause, prevention, diagnosis, and treatment of cancer; cancer survivorship; and the continuing care of cancer patients and their families. NCI, Center for Global Health (NCI/CGH) supports the NCI mission by advancing global cancer research, and by coordinating NCI engagement in global cancer control. NCI/CGH has four strategic goals: (1) support innovative, impactful research that addresses key scientific issues in global cancer control and/or leverages unique scientific opportunities afforded by global collaboration; (2) support global cancer research training, particularly in low- and middle-income countries, that enables impactful global scientific collaboration; (3) promote the integration of current scientific knowledge in global cancer control; and (4) represent the NCI and promote its engagement with key partners in global cancer control.
Silver Sponsor
The American Cancer Society works to save lives and reduce suffering from cancer. We are part of the Allied Against Cancer alliance, working with the African Cancer Coalition, National Comprehensive Cancer Network, and the Clinton Health Access Initiative to improve access to cancer treatment in Sub-Saharan Africa.
The Alliance works in four areas: 1) standardizing evidence-based treatment with the NCCN Harmonized Guidelines for Sub-Saharan Africa; 2) improving access to high-quality, affordable cancer medicines with the Cancer Access Partnership; 3) creating a culture of occupational and environmental safety for the handling of hazardous medicines in the ChemoSafe program; and 4) improving access to essential pain medicines in the Treat the Pain program.
We partner with cancer centers and health ministries in 13 countries in Sub-Saharan Africa.
To find out more about these projects, visit the Allied Against Cancer booth or visit us at Alliedagainstcancer.org
Bronze Sponsors
HARMONY is dedicated to advancing equitable, high-quality cancer patient care globally. Stakeholders in oncology agree that harmonizing approval processes and clinical trials globally will benefit patients and save lives. While there is a movement toward harmonisation, there is no focused effort to achieve this end.
The existing disparities in clinical trial accessibility deny many cancer patients potential life-sparing benefits. This disharmony hampers the development and regulatory approval of cancer treatments worldwide. Although the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has provided guidelines and encouraged criteria, their implementation remains unfulfilled. To achieve harmonisation, a unified and collaborative framework is required. Within this framework, success is defined as “A drug approved anywhere will be available everywhere for life-threatening disease”.
It is imperative that we raise awareness about the advantages of globally harmonised clinical trials, unite international experts, and leverage existing networks, organisations, and advocates.
HARMONY, a keystone initiative of the Society for Translational Oncology (STO), is dedicated to saving cancer patients the world over.
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit www.varian.com.
Supporters
